Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pramipexole versus gabapentin for restless legs syndrome in hemodialysis patients
IRCT20191106045350N1Phase 3Completed
- Sponsor
- Qazvin University of Medical Sciences
- Start
- Sep 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in restless legs syndrome (RLS) comparing Pramipexole with Gabapentin (2 arms). Primary endpoint: Change in severity of restless legs syndrome. Started Sep 2018; status: completed.
02
Drugs
pramipexolegabapentin
03
Conditions
restless legs syndrome (RLS)
Beyond the preview
Go deeper on IRCT20191106045350N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20191106045350N1.